These data encourage targeted studies to measure CRH in CSF and further evaluate its potential as a biomarker to strengthen the robustness of our findings and to understand what mechanism CRH might reflect in parkinsonian disorders. The gene discussed is CRH; the disease is parkinsonian disorder.